Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 31, 2015
Refining the definition of clinically important mineral and bone disorder in hemodialysis patientsMark D Danese, Marc Halperin, Kimberly A Lowe, et al.
International Journal of Nephrology|April 21, 2012
Impact of hemodialysis catheter dysfunction on dialysis and other medical services: an observational cohort studyRobert I Griffiths, Britt B Newsome, Grace Leung, et al.
Cancer Investigation|September 21, 2011
Infused therapy and survival in older patients diagnosed with metastatic breast cancer who received trastuzumabRobert I Griffiths, Deepa Lalla, Robert J Herbert, et al.
Journal of Gastrointestinal Cancer|March 11, 2016
Racial and Ethnic Variability in the Prevalence and Incidence of Comorbidities Associated with Gastric Cancer in the United StatesKimberly A Lowe, Mark D Danese, Michelle L Gleeson, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|October 5, 2020
Fibroblast growth factor 23 as a risk factor for cardiovascular events and mortality in patients in the EVOLVE trialGeoffrey A Block, Glenn M Chertow, Kerry Cooper, et al.
Blood|December 31, 2010
An observational study of outcomes after initial infused therapy in Medicare patients diagnosed with chronic lymphocytic leukemiaMark D Danese, Robert I Griffiths, Michelle Gleeson, et al.
Leukemia & Lymphoma|January 12, 2019
Treatment patterns, survival, and hospitalization in adult patients with acute lymphoblastic leukemia: an observational cohort study using SEER Medicare dataMark D Danese, Aaron Katz, Karynsa Cetin, et al.
American Journal of Nephrology|September 23, 2020
Real World Use and Effects of Calcimimetics in Treating Mineral and Bone Disorder in Hemodialysis PatientsMark D Danese, Deborah Lubeck, Vasily Belozeroff, et al.
Advances in Therapy|April 17, 2022
Association Between Granulocyte Colony-Stimulating Factor (G-CSF) Use and Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Among Elderly Patients with Breast, Lung, or Prostate CancerMark D Danese, Jennifer Schenfeld, Jaime Shaw, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|January 20, 2016
Quality adjusted life year gains associated with administration of recombinant tissue-type plasminogen activator for treatment of acute ischemic stroke: 1998-2011Deborah P Lubeck, Mark D Danese, Jennifer Duryea, et al.
Pageof 6